Denmark's business minister said on Friday that U.S. President Donald Trump's executive order which directs drugmakers to lower drug prices would create uncertainty and challenges for Danish pharmaceutical companies.

Experts said Trump’s action could potentially lower the cost of prescription drugs, perhaps by the 30 percent to 80 percent scale Trump said, but they cautioned that the order’s required procedural steps would make it far from an immediate fix.